Is melatonin a suitable hypnotic for the elderly?
Authors:
Pavlíčková Ludmila
Authors‘ workplace:
Oddělení geriatrie a následné péče FTN Praha
Published in:
Geriatrie a Gerontologie 2023, 12, č. 1: 36-40
Category:
Review Article
Overview
Sleep disorders are common among seniors. Benzodiazepine and nonbenzodiazepine hypnotics are not recommended for seniors because of the risk of addiction and serious adverse effects. Melatonin is an endogenous mediator of circadian rhythm and it can be used as an effective hypnotic. It has no serious adverse effects and therefore it is more suitable for seniors. Melatonin can be recommended to promote sleep by seniors without cognitive impairment and those with mild cognitive impairment; for people with advanced dementia melatonin has not an apparent hypnotic effect. Eventual neuroprotective effects of melatonin should be verified in randomized controlled trials.
Keywords:
sleep – Melatonin – circadian rhythm – neurodegenerative disorders
Sources
1. Kučerová Z. Poruchy spánku u seniorů. Geri a Gero 2022; 11 (3): 129–138.
2. Suni E. Stages of Sleep. Sleep Foundation. 2021. Dostupné z: https://www.sleepfoundation. org/stages-of-sleep
3. Carley DW, Farabi SS. Physiology of Sleep. Diabetes Spectr 2016; 29 (1): 5–9.
4. Boutin JA, Jockers R. Melatonin controversies, an update. J Pineal Res 2021; 70: e12702.
5. Chen D, Zhang T, Lee TH. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. Biomolecules 2020; 10(8): 1158.
6. Kim JH, Duffy J. Circadian Rhythm Sleep-Wake Disorders in Older Adults. Sleep Med Clin 2018; 13 (1): 39–50.
7. Sakai K, Yamamoto Z, Ikeuchi T. Vertebrates originally possess four functional subtypes of G protein- coupled melatonin receptor. Sci Rep 2019; 9(1): 9465.
8. Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DP. Melatonin and sleep in aging population. Exp Gerontol 2005; 40(12): 911– 925.
9. Lewy AJ. Melatonin and Human Chronobiology. Cold Spring Harb Symp Quant Biol 2007; 72: 623–636.
10. Aulinas A. Physiology of the Pineal Gland and Melatonin. Comprehensive free online endocrinology book, 2019.
11. Sadanandan N, Cozene B, Cho J, et al. Melatonin – A Potent Therapeutic for Stroke and Stroke- -Related Dementia. Antioxidants (Basel) 2020; 9(8): 672.
12. Spinedi E, Cardinali DP. Neuroendocrine- Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer‘s Disease and Melatonin. Neuroendocrinology 2019; 108: 354–364.
13. Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 2005; 20(12): 1151–8.
14. Cardinali DP. Melatonin: Clinical Perspectives in Neurodegeneration. Front Endocrinol 2019; 10: 480.
15. Blackman J, Swirski M, Clynes J, et al. Pharmacological and non- -pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer’s disease: A systematic review. J Sleep Res 2021; 30(4): e13229.
16. Wu YU, Zhou JN, Van Heerikhuize J, et al. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease. Neurobiol Aging 2007; 28 (8): 1239–1247.
17. Wilson S, Anderson K, Baldwin D, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol 2019; 33(8): 923–947.
18. Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLoS One 2013; 8(5): e63773.
19. McCleery J, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev 2020; 11 (11): CD009178.
20. Aurora RN, Zak RS, Maganti RK, et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 2010; 6: 85–95.
21. Furuya M, Miyaoka T, Yasuda H, et al. Ramelteon as adjunctive therapy for delirium referred to a consultation-liaison psychiatry service: a retrospective analysis. Int J Geriatr Psychiatry 2015; 30(9): 994–995.
22. Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab 2018; 62(4): 472– 479.
Labels
Geriatrics General practitioner for adults Orthopaedic prostheticsArticle was published in
Geriatrics and Gerontology
2023 Issue 1
Most read in this issue
- Frailty evaluation in a geriatric patient. Clinical guidelines of the Board of the Czech Society of Gerontology and Geriatrics
- Is melatonin a suitable hypnotic for the elderly?
- Recommendations for screening and risk stratification of falls in the elderly in the light of the new ”World guidelines for falls prevention and management for older adults“
- Pharmacotherapy of chronic heart failure in the elderly